Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2020

Oct 30, 2020

30198_dirs_2020-10-30_82d05f56-65ff-441a-a5ce-d574e9cec246.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-10-29

Reporting Person: SAYER KEVIN R (Director, President, CEO and Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-10-29 Common Stock S 600 $333.6273 Disposed 141977 Direct
2020-10-29 Common Stock S 2910 $335.5285 Disposed 139067 Direct
2020-10-29 Common Stock S 2428 $336.4331 Disposed 136639 Direct
2020-10-29 Common Stock S 1676 $337.5023 Disposed 134963 Direct
2020-10-29 Common Stock S 1200 $339.9286 Disposed 133763 Direct
2020-10-29 Common Stock S 1430 $341.553 Disposed 132333 Direct
2020-10-29 Common Stock S 547 $342.5249 Disposed 131786 Direct
2020-10-29 Common Stock S 400 $343.61 Disposed 131386 Direct
2020-10-29 Common Stock S 200 $345.26 Disposed 131186 Direct
2020-10-29 Common Stock S 800 $347.91 Disposed 130386 Direct
2020-10-29 Common Stock S 609 $350.2776 Disposed 129777 Direct
2020-10-29 Common Stock S 300 $351.6417 Disposed 129477 Direct
2020-10-29 Common Stock S 510 $352.76 Disposed 128967 Direct
2020-10-29 Common Stock S 220 $354.0 Disposed 128747 Direct

Footnotes

F1: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: This transaction was executed in multiple trades at prices ranging from $333.282 to $334.22. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3: Included in this number are 56,792 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 17,915 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 13,424 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

F4: This transaction was executed in multiple trades at prices ranging from $334.94 to $335.89. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F5: This transaction was executed in multiple trades at prices ranging from $335.98 to $336.935. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F6: This transaction was executed in multiple trades at prices ranging from $337.015 to $337.769. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F7: This transaction was executed in multiple trades at prices ranging from $339.28 to $340.26. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F8: This transaction was executed in multiple trades at prices ranging from $341.125 to $342.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F9: This transaction was executed in multiple trades at prices ranging from $342.30 to $342.85. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F10: This transaction was executed in multiple trades at prices ranging from $345.255 to $345.265. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F11: This transaction was executed in multiple trades at prices ranging from $350.175 to $350.30. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F12: This transaction was executed in multiple trades at prices ranging from $351.405 to $352.115. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.